Project Number 1R21AG060208-01 Agency/Funding Organization NIA Funding Year 2018 View Full Project Details for Development of Splice Modulating Oligonucleotides Targeting RAGE as a Treatment for Alzheimers Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) a. Amyloid beta Researcher and Organization Principal Investigator TALLENT, MELANIE K Principal Investigator First Name MELANIE K Principal Investigator Last Name TALLENT Awardee Organization LIFESPLICE PHARMA, LLC Awardee State Pennsylvania Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-16-042: DRUG DISCOVERY FOR NERVOUS SYSTEM DISORDERS (R21) FY Overall Cost $245,000 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
